Use of ketonal in lumbago
| Autor: | P. R. Kamchatnov, Kh. Ya. Umarova |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2015 |
| Předmět: | |
| Zdroj: | Нервно-мышечные болезни, Vol 0, Iss 1, Pp 47-53 (2015) |
| Druh dokumentu: | article |
| ISSN: | 2222-8721 2413-0443 |
| DOI: | 10.17650/2222-8721-2014-0-1-48-61 |
| Popis: | Lumbago is one of the most common musculoskeletal pain syndromes. The course of lumbago shows a tendency towards frequent relapses and is associated with the significant material costs of medical care. A wide range of analgesics, nonsteroidal anti-inflammatory drugs in particular, whose administration may be linked with an increased risk for adverse visceral reactions, is used to treat patient with lumbago. The risk of their side effects may be reduced by the extensive use of non-drug treatments and the early expansion of a motor regimen in a patient. Therapeutic effectiveness in reducing the likelihood of adverse reactions may be provided by short-term treatment with effective drugs. The advantages of using ketoprofen (ketonal) formulations in patients with lumbago are considered. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|